{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:45:32Z","timestamp":1795041932709,"version":"4.10.2"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128947","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:04:22Z","timestamp":1785542662000},"page":"128947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Invasive pneumococcal disease in Latin America: serotype distribution and vaccine coverage among adults in Mexico, Brazil, and Argentina"],"prefix":"10.1016","volume":"88","author":[{"given":"Amanda","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Urrego-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cervenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan Kumar","family":"Paluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cossrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10369","key":"10.1016\/j.vaccine.2026.128947_bb0005","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128947_bb0010","series-title":"Pneumococcal disease","article-title":"Clinical overview of pneumococcal disease","author":"CDC","year":"2025"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128947_bb0015","first-page":"502","article-title":"Impacto de la vacuna neumoc\u00f3cica conjugada 13-valente en la incidencia de neumon\u00eda consolidante en menores de 5 anos en el partido de Pilar, Buenos Aires: estudio de base poblacional","volume":"113","author":"Gentile","year":"2015","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vaccine.2026.128947_bb0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vhri.2021.08.003","article-title":"Cost-effectiveness of pneumococcal vaccines for adults aged 65 years and older in Argentina","volume":"28","author":"Giglio","year":"2022","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.vaccine.2026.128947_bb0025","unstructured":"Ministerio de Salud de la Naci\u00f3n Argentina. Vacuna contra neumococo: transici\u00f3n a la vacuna contra 20 serotipos en el Calendario Nacional de Vacunaci\u00f3n. Published online 2025. https:\/\/www.argentina.gob.ar\/sites\/default\/files\/2018\/02\/vacuna_neumococo_transicion_26022025.pdf."},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2026.128947_bb0030","article-title":"46 anos do Programa Nacional de Imuniza\u00e7\u00f5es: uma hist\u00f3ria repleta de conquistas e desafios a serem superados","volume":"36","author":"Domingues","year":"2020","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.vaccine.2026.128947_bb0035","series-title":"Manual dos centros de refer\u00eancia para imunobiol\u00f3gicos especiais","author":"Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Imuniza\u00e7\u00e3o e Doen\u00e7as Transmiss\u00edveis","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128947_bb0040","unstructured":"Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Imuniza\u00e7\u00e3o e Doen\u00e7as Transmiss\u00edveis, Coordena\u00e7\u00e3o-Geral do Programa Nacional de Imuniza\u00e7\u00f5es. Informe T\u00e9cnico para Implanta\u00e7\u00e3o da Vacina Pneumoc\u00f3cica conjugada 13-valente em pacientes de risco \u2265 de 5 anos de idade. https:\/\/sbim.org.br\/images\/files\/notas-tecnicas\/informe-tecnico-pneumo13-pacientesderisco-menoresde5anos.pdf."},{"key":"10.1016\/j.vaccine.2026.128947_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2017.02.005","article-title":"Changing trends in serotypes of S. pneumoniae isolates causing invasive and non-invasive diseases in unvaccinated population in Mexico (2000-2014)","volume":"58","author":"Carnalla-Barajas","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128947_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127031","article-title":"Distribution of pneumococcal serotypes causing invasive and non-invasive diseases in children in Mexico after introduction of PCV13 (2012\u20132023). Results from the GIVEBPVac group","volume":"55","author":"Soto-Noguer\u00f3n","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128947_bb0055","unstructured":"Centro Nacional para la Salud de la Infancia y Adolescencia, Gobierno de Mexico. LINEAMIENTOS GENERALES PVU 2026. gob.mx. Accessed February 13, 2026. http:\/\/www.gob.mx\/salud|censia\/documentos\/lineamientos-generales-pvu-2026."},{"key":"10.1016\/j.vaccine.2026.128947_bb0060","unstructured":"World Health Organization. Laboratory quality management system: handbook. Accessed February 13, 2026. https:\/\/www.who.int\/publications\/i\/item\/9789241548274."},{"key":"10.1016\/j.vaccine.2026.128947_bb0065","unstructured":"World Health Organization. SIREVA - PAHO\/WHO | Pan American Health Organization. Accessed April 2, 2026. https:\/\/www.paho.org\/en\/sireva."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128947_bb0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(20)30489-8","article-title":"The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006\u201317): a multicentre, retrospective observational study","volume":"21","author":"Agudelo","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128947_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.108247","article-title":"Burden and serotype distribution of invasive pneumococcal disease among high-risk patients from Latin America and the Caribbean: a systematic review and meta-analysis","volume":"163","author":"Bardach","year":"2026","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128947_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304978","article-title":"Invasive pneumococcal disease in Latin America and the Caribbean: serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis","volume":"19","author":"Bardach","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128947_bb0085","unstructured":"Sociedade Brasileira de Geriatria e Gerontologia, Sociedade Brasileira de Imunizacoes. CALEND\u00c1RIO DE VACINA\u00c7\u00c3O IDOSO 60+ 2025\u20132026. https:\/\/sbgg.org.br\/wp-content\/uploads\/2025\/12\/Calend_rio_de_vacina.pdf."},{"key":"10.1016\/j.vaccine.2026.128947_bb0090","series-title":"Lineamientos T\u00e9cnicos y Manual de Vacunaci\u00f3n: Vacuna Antineumoc\u00f3cica Conjugada de 20 serotipos en mayores de 5 a\u00f1os","author":"Milei","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128947_bb0095","unstructured":"INSP. Vigilancia de enfermedades bacterianas prevenibles por vacunaci\u00f3n - Portal INSP. Accessed February 13, 2026. https:\/\/www.insp.mx\/avisos\/vigilancia-de-enfermedades-bacterianas-prevenibles-por-vacunacion."},{"key":"10.1016\/j.vaccine.2026.128947_bb0100","author":"INEI - ANLIS Malbr\u00e1n"},{"key":"10.1016\/j.vaccine.2026.128947_bb0105","unstructured":"Instituto Adolfo Lutz. Bacteriologia: N\u00facleo de Meningites, Pneumonias e Infec\u00e7\u00f5es Pneumoc\u00f3cicas. https:\/\/www.ial.sp.gov.br\/ial\/centros-tecnicos\/centro-de-bacteriologia\/nucleoslaboratorios\/nucleo-de-meningites-pneumonias-e-infeccoes-pneumococicas."},{"key":"10.1016\/j.vaccine.2026.128947_bb0110","unstructured":"Duarte Valderrama C, Rodriguez Cerquera M, Sanabria Cruz OM, Realpe Delgado ME. Procedimientos para el diagn\u00f3stico de Neumon\u00edas y Meningitis Bacterianas y la caracterizaci\u00f3n de cepas de Streptococcus pneumoniae y Haemophilus influenzae, SIREVA II. Grupo Microbiol Inst Nac Salud Bogot\u00e1 \u2013 Colomb Organ Panam Dela Salud."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128947_bb0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s43856-025-01106-z","article-title":"Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine V116","volume":"5","author":"Li","year":"2025","journal-title":"Commun Med"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128947_bb0120","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1473-3099(24)00344-X","article-title":"Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial","volume":"24","author":"Platt","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128947_bb0125","article-title":"Invasive pneumococcal disease in Argentina: a snapshot from a retrospective observational study on serotypes, antimicrobial resistance, and the potential impact of the COVID-19 pandemic (2018\u20132022)","volume":"46","author":"Zintgraff","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.vaccine.2026.128947_bb0130","series-title":"ABCs Bact Facts Interactive Data Dashboard","author":"CDC","year":"2025"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:38:55Z","timestamp":1789504735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"alternative-id":["S0264410X26007565"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128947","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive pneumococcal disease in Latin America: serotype distribution and vaccine coverage among adults in Mexico, Brazil, and Argentina","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128947"}}